Switzerland pre-orders 4.5 million doses of Covid-19 vaccine
Arms race: countries and companies are scrambling for a Covid-19 vaccine.
Associated Press
The Swiss government has signed a deal with US biotech firm Moderna to secure early access to 4.5 million doses of a Covid-19 vaccine currently in development.
Swiss authorities saidExternal link on Friday that Moderna was “already at an advanced stage with its vaccine project”, but they did not mention a possible time frame for delivery.
They also said the 4.5 million batches would make it possible to vaccinate 2.25 million people, since double doses are expected to be necessary.
Moderna’s Covid-19 vaccine, with ingredients manufactured by Swiss pharma firm Lonza, is based on an innovative mRNA technology, the government writes:
“mRNA is a kind of messenger molecule that carries the building instructions for the production of proteins. This tells the body’s cells how to produce the virus protein. As soon as the protein is produced in the body, it is identified as an antigen by the immune system, which then produces antibodies against the virus, thus preparing the body to combat the real virus.”
The government also says that Switzerland is “one of the first countries to conclude an agreement with Moderna”. The US has also been linked to a deal.
In parallel to this agreement, the Swiss government is continuing talks with other companies in what it calls a “diversified approach” to gaining access to a vaccine. It also continues to support multilateral projects for the fair distribution of a future cure, it writes.
The federal government has earmarked CHF300 million ($329 million) for the procurement of a vaccine.
Popular Stories
More
Swiss Abroad
The citizenship obstacle course facing spouses of Swiss Abroad
This content was published on
The Ethos Foundation recommends that shareholders vote against all compensation-related items at the Annual General Meeting on March 7.
Top Swiss firms close to reaching gender quota in boards
This content was published on
The proportion of women on the boards of directors of the fifty largest listed companies in Switzerland currently stands at 28%.
Swiss committee wants to end government resignations during legislative term
This content was published on
Members of the Federal Council should no longer be able to leave office before the end of their term, according to a House of Representatives committee.
Swiss government seat: Ritter and Pfister nominated to succeed Amherd
This content was published on
Markus Ritter from St Gallen and Martin Pfister from Zug were officially nominated by the Centre Party on Friday to succeed Defence Minister Viola Amherd.
Top Swiss court rejects Russian request for administrative tax assistance
This content was published on
There is currently no reason to transmit banking information to the Russian Federation, the Swiss Federal Court has ruled.
After strike by radiologists, doctors demonstrate in Bern
This content was published on
Following a strike by radiology technicians in Fribourg, doctors, vets, dentists and chiropractors expressed their frustration on Friday outside parliament in the Swiss capital.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Government earmarks CHF300 million to secure Covid-19 vaccine
This content was published on
The Swiss government is setting aside funds to procure enough doses of a Covid-19 vaccine for the country’s 8.6 million population.
This content was published on
It’s the question we all want an answer to: when will there be a vaccine against Covid-19? And how is fair access being negotiated?
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.